Ambalal Sarabhai Enterprises Limited · NSE:AMBALALSA
Ambalal Sarabhai Enterprises — Shareholder Meeting (July 2025)
38 slides from Ambalal Sarabhai Enterprises's shareholder meeting presentation, Jul 29, 2025
Slide 1: Corporate Overview 2025
Empowering Progress, Inspiring Tomorrow… www.ase.life Corporate Overview 2025 1
Slide 2: The ASE Umbrella
The ASC Umbrella ASCII = vovantis mines LABORATORIES Pharma Private Limited oc | TED ® a __ o: CoSara’ ee Diagnostics SYSTRONICS Ambalal Sarabhai Enterprises Limited °. =e S PVT.LTD “alll Mins = SUVIK = TELERAD SARABHAI CHEMICALS 2
Slide 3: Sarabhai Campus, Ranoli, Gujarat
Sarabhai Campus Ranoli, Gujarat 3
Slide 4: Group: API, Finished Dosages, Intermediates
Group API (ACTIVE PHARMACEUTICAL INGREDIENTS) FINISHED DOSAGES INTERMEDIATES 4
Slide 5: Finished Dosages
FINISHEDDOSAGES 1. More than 100 Registered Products Worldwide. 2. Exports to More than 40 Countries. 3. Product Manufactured under QC/QA Supervision at Selected CMO Sites in India. 4. More than 10 CMO sites added for enhance production. 5
Slide 6: Offices in New York, Mumbai, Vadodara
New York, USA Mumbai, India Vadodara, India ASENCE Group has offices in USA through Asence Inc. & Manufacturing Plant & Office in India through Asence Pharma. 6
Slide 7: API Manufacturing Facility
APIManufacturingFacility 7 AERIAL VIEW OF MANUFACTURING FACILITYAT RANOLI – VADODARA,GUJARAT ( INDIA )
Slide 8: Latest Updates
Latest Updates BEZAFIBRATE Lipid Lowering (New Product developed) Hydroxyurea (Oncology, CEP Filed) Methotrexate (Oncology) 8
Slide 9: API Manufacturing & Exported by Asence
API Manufacturing & Exported by Asence ANTICOAGULANT ANTIOXIDANT - Acenocoumarol BP - Ascorbyl Palmitate BP/EP/USP ANTIPSYCHOTIC ONCOLOGY - Fluphenazine Decanoate BP/EP/USP/IP - Hydroxy Urea BP/EP/USP/ IP LOCAL ANAESTHETIC INTERMEDIATES - Bupivacaine Hydrochloride BP/EP/USP/IP - Cerium Chloride Anhy
Slide 10: API Plant
Commissioned in June, 2023 Oncology (Block-1) High Value Low Volume API Synthetic API (Block-4) Plant (Block-2) Intermediates (Block-3) All Areas and Blocks are ACTIVE 10
Slide 11: Intermediate Stage Mfg. Area
Intermediate Stage Mfg. Area 11
Slide 12: Centrifuge Rotocone Vacuum Dryer
Centrifuge Rotocone Vacuum Dryer 12
Slide 13: Process Development Lab
Process Development Lab aseice
Slide 14: Amphotericin B
Amphotericin B Oral/Parenteral/Lyophilized New Plant 2009 The most powerful antifungal molecule in the world. JAPAN USFDA EU WHO PMDA Synbiotics (APPL) has been granted Certificate of Suitability (CEP) for Amphotericin B, intended for use in the manufacture of parenteral preparations, as of June 13,
Slide 15: Luna, India
synbiotics a) ||| TED Luna, India 15
Slide 16: Luna, India
synbiotics | | || TED Luna, India 16
Slide 17: Vovantis Laboratories: effervescent technology
Vovantis Laboratories Private Limited is a global leader in the manufacturing of high- quality effervescent products, specializing in oral powders and tablets. Leading player in effervescent technology globally . 17
Slide 18: Ranoli, India
Ranoli, India ase 18
Slide 19: New Facility (Unit 2)
With the addition of new facility (Unit 2), a state-of-the- art manufacturing facility compliant with WHO-GMP and USFDA standards, the company has expanded its capabilities to include the production of General tablets, Sachets, and Capsules. 19
Slide 20: Vovantis Unit, Ranoli, India
~ vovantis LABORATORIES UNIT 2 ase Ranoli, India 20
Slide 21: Vovantis Unit, Ranoli, India
~ vovantis LABORATORIES UNIT 2 Ranoli, India 4
Slide 22: Certificates
~ ~ voval OR I Ss Certificates vovantis UNIT 2 PEN U.S. FOOD & DRUG ADMINISTRATION UL Solutions THE REPUBLIC OF YEMEN Ministry of Public Health preg GUA’ DELA MALA ICA DE — Citi ’ FDA. -~ : ssa oF UNITED ARAB EMIRATES MINISTRY OF HEALTH & PREVENTION Food and Drug Administration PHILIPPINES MINISTRY
Slide 23: Revolutionary Molecular Diagnostics Launched
Revolutionary Molecular Diagnostics Launched 8th April, 2019 PCR & Rapid Diagnostic Tests 23
Slide 24: Classified Area for RT-PCR Kit Production
CLASSIFIED AREA FOR RT-PCR KIT PRODUCTION Ranoli, India Confidential 24
Slide 25: Product Portfolio
Product Portfolio Research Use CDSCO Only SARAGENE® Approved SARAGENE® 1. Mycobacterium Tuberculosis • HLA-B27 2. Malaria • Influenza A H1N1 3. Hepatitis B (Qualitative) 4. Hepatitis C (Qualitative) SARAPLEX® 5. Human Papillomavirus 16/18 • Sexually Transmitted Infection Panel 6. Human Papillomaviru
Slide 26: Co-Dx PCR Pro Testing Platform
Co-Dx PCR Pro™ Testing Platform • Accessible, lab-quality testing • Device + testing cartridges + Bluetooth connectivity • 2022 AACC award - Disruptive Technology Semi-Finalist • Manufacturing Test License received For HPV & TB Disclaimer: Co-Dx PCR Home and its associated tests are subject to FDA r
Slide 27: Co-Dx PCR Pro Trial - HPV Assay
Team Co-Dx™ PCR Pro™ Trial- HPV Assay developed at CoSara 27
Slide 28: Make In India: Oligonucleotide Synthesis Facility
In Support For Make In India Initiative Newly Inaugurated Oligonucleotide Synthesis Facility DEC 2024 28
Slide 29: Our Electronics Instruments Company
Our Electronics Instruments Company Ahmedabad Leading manufacturer of analytical test and measuring equipment. 29
Slide 30: New Product Addition in FY 2025-26
Latest Updates New Product Addition in FY 2025-26 Android based Visible Spectrophotometer 168A Android based double beam UV VIS Spectrophotometer 2205A 30
Slide 31: Range of New Product After a Decade
1 st Range of New Product After a Decade 31
Slide 32: Key Principals: Broadcast & Professional A/V Products
Key Principals Broadcast & Professional A/V Products 32
Slide 33: SuvikHitek Pharma, Generic and Veterinary Divisions
SuvikHitek Pvt. Limited – Pharma Division SuvikHitek – Pharma Division is a national company, re-launching domestic operations in the market of Sarabhai with same high quality products. SuvikHitek – Pharma Division is marketing through ethical promotion through our 100 franchisee (business assoc
Slide 34: Veterinary Product List
Product List Veterinary www.sarabhaichemicals.com 34
Slide 35: Human Product List
Product List Human www.sarabhaichemicals.com 35
Slide 36: ASE Consolidated Results: Total Income and PBT
ASE CONSOLIDATED RESULTS Total Income and PBT (Before Exceptional Items) Rs in Crores 300 250 238.76 207.57 200 194.22 182.77 183.95 157.35 157.89 150.65 150 100 69.31 50 32.54 14.94 14.83 11.83 7.96 8.21 6.65 0 2017-18 2018-19 2019-20 2020-21 2021-22 2022-23 2023-24 2024-25 Total Income PBT 36
Slide 37: Sarabhai House, Ahmedabad Corporate Office
Sarabhai House, Ahmedabad 37 Corporate Office
Slide 38: Thank You
Thank You… Contact us : Ambalal Sarabhai Enterprises Limited Shanti Sadan, Mirzapur Road, Ahmedabad 380 001, INDIA Mo. : +91 90990 13477 Email : dpunjani@ase.life 38
Ambalal Sarabhai Enterprises — Shareholder Meeting (July 2025) on 6ix